Ozempic Pen Not Delivering Full Doses as Expected

Ozempic Pen Not Delivering Full Doses as Expected

I started using Ozempic 0.25 mg with my doctor's approval. I weigh 82 kg and have a body mass index (BMI) above 30.

Starting on May 16, 2026, I administered a total of three doses of 0.25 mg in accordance with the patient information leaflet and the recommended injection techniques. Although the pen is stated to contain four doses in total, I have administered only three doses so far, with one dose supposedly remaining.

For each injection, I carefully selected the correct dose, fully pressed the injection button to ensure that the medication was delivered, and kept the needle in place for the recommended amount of time before removing it.

Despite following these steps, I did not observe the expected reduction in the amount of medication remaining in the pen after these applications. Based on my observations, the amount of liquid still visible in the pen raises concerns that the full doses may not have been delivered as intended.

Additionally, during my first injection, I noticed that some of the medication remained on the surface of my skin. This raises the possibility of a technical issue with the injection system or the dose delivery mechanism.

Furthermore, while researching similar user experiences, I came across complaints on various platforms, particularly consumer complaint websites, where other users also reported that medication remained inside their pens and expressed concerns that they had not received their full doses. Some users also mentioned that the needle tips seemed too short or that they experienced technical difficulties during administration.

The most concerning aspect of this situation is that the pen mechanism does not provide users with definitive confirmation that the entire dose has been successfully delivered. The fact that the visible liquid level has not decreased as expected further reinforces my concerns.

Although I have carefully followed all the recommended administration steps, these issues have still occurred. Therefore, I request that the following aspects be evaluated as part of a product-specific technical investigation:

- The manufacturing and filling tolerances of the product bearing batch number **RP5V040**.
- The technical validation method used to verify that the pen's dose delivery mechanism administers the full dose.
- The acceptable range of residual medication normally expected to remain inside the pen.
- Potential device-related factors that could cause medication loss during injection.

As I believe this situation may affect my treatment process and the effective administration of the medication, I request that the product be thoroughly investigated and, if deemed appropriate, replaced or refunded.

My intention is not to make unfounded allegations, but rather to obtain technical clarification on whether the medication I am using as part of my treatment is actually being administered in the correct and complete dosage.

For this reason, I kindly request that this matter be handled as a **technical quality investigation rather than a routine customer feedback report**, and that I receive a specific, detailed, and satisfactory response explaining the findings.

Comments